BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 28249094)

  • 21. Ischemic postconditioning during primary percutaneous coronary intervention.
    Mentias A; Mahmoud AN; Elgendy IY; Elgendy AY; Barakat AF; Abuzaid AS; Saad M; Kapadia SR
    Catheter Cardiovasc Interv; 2017 Dec; 90(7):1059-1067. PubMed ID: 28296005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between gender and short-term outcome in patients with ST elevation myocardial infraction participating in the international, prospective, randomised Administration of Ticagrelor in the catheterisation Laboratory or in the Ambulance for New ST elevation myocardial Infarction to open the Coronary artery (ATLANTIC) trial: a prespecified analysis.
    Venetsanos D; Sederholm Lawesson S; Alfredsson J; Janzon M; Cequier A; Chettibi M; Goodman SG; Van't Hof AW; Montalescot G; Swahn E
    BMJ Open; 2017 Sep; 7(9):e015241. PubMed ID: 28939567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiography-guided Multivessel Percutaneous Coronary Intervention Versus Ischemia-guided Percutaneous Coronary Intervention Versus Medical Therapy in the Management of Significant Disease in Non-Infarct-related Arteries in ST-Elevation Myocardial Infarction Patients With Multivessel Coronary Disease.
    Perera D; Crake T; Lee V
    Crit Pathw Cardiol; 2018 Jun; 17(2):77-82. PubMed ID: 29768315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of ischaemic postconditioning on outcomes of patients with ST-segment elevation myocardial infarction who underwent primary percutaneous coronary intervention: a meta-analysis.
    Xing Z; Tang L; Huang J; Peng X; Hu X
    BMJ Open; 2019 Mar; 9(3):e022509. PubMed ID: 30904835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of serum transaminases with short- and long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Gao M; Cheng Y; Zheng Y; Zhang W; Wang L; Qin L
    BMC Cardiovasc Disord; 2017 Jan; 17(1):43. PubMed ID: 28129742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ischemic Postconditioning Before Percutaneous Coronary Intervention for Acute ST-Segment Elevation Myocardial Infarction Reduces Contrast-induced Nephropathy and Improves Long-term Prognosis.
    Wang YY; Li T; Liu YW; Wang Y; Hu XM; Gao WQ; Wu P; Li X; Peng WJ; Gao W; Yu GD; Liu BJ
    Arch Med Res; 2016 Aug; 47(6):483-488. PubMed ID: 27986129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Remote ischemic postconditioning during percutaneous coronary interventions: remote ischemic postconditioning-percutaneous coronary intervention randomized trial.
    Lavi S; D'Alfonso S; Diamantouros P; Camuglia A; Garg P; Teefy P; Jablonsky G; Sridhar K; Lavi R
    Circ Cardiovasc Interv; 2014 Apr; 7(2):225-32. PubMed ID: 24692535
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship Between Arterial Access and Outcomes in ST-Elevation Myocardial Infarction With a Pharmacoinvasive Versus Primary Percutaneous Coronary Intervention Strategy: Insights From the STrategic Reperfusion Early After Myocardial Infarction (STREAM) Study.
    Shavadia J; Welsh R; Gershlick A; Zheng Y; Huber K; Halvorsen S; Steg PG; Van de Werf F; Armstrong PW
    J Am Heart Assoc; 2016 Jun; 5(6):. PubMed ID: 28525886
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of Effect of Ischemic Postconditioning on Cardiovascular Mortality in Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention With Versus Without Thrombectomy.
    Madsen JM; Glinge C; Jabbari R; Nepper-Christensen L; Høfsten DE; Tilsted HH; Holmvang L; Pedersen F; Joshi FR; Sørensen R; Bang LE; Bøtker HE; Terkelsen CJ; Mæng M; Jensen LO; Aarøe J; Kelbæk H; Torp-Pedersen C; Køber L; Lønborg JT; Engstrøm T
    Am J Cardiol; 2022 Mar; 166():18-24. PubMed ID: 34930614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of Thrombus Aspiration With Time and Mortality Among Patients With ST-Segment Elevation Myocardial Infarction: A Post Hoc Analysis of the Randomized TOTAL Trial.
    Moxham R; Džavík V; Cairns J; Natarajan MK; Bainey KR; Akl E; Tsang MB; Lavi S; Cantor WJ; Madan M; Liu YY; Jolly SS
    JAMA Netw Open; 2021 Mar; 4(3):e213505. PubMed ID: 33769510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardioprotective Effects of Intracoronary Morphine in ST-Segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention: A Prospective, Randomized Trial.
    Gwag HB; Kim EK; Park TK; Lee JM; Yang JH; Song YB; Choi JH; Choi SH; Lee SH; Chang SA; Park SJ; Lee SC; Park SW; Jang WJ; Lee M; Chun WJ; Oh JH; Park YH; Choe YH; Gwon HC; Hahn JY
    J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28373244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benefit From Reperfusion With Primary Percutaneous Coronary Intervention Beyond 12 Hours of Symptom Duration in Patients With ST-Segment-Elevation Myocardial Infarction.
    Nepper-Christensen L; Lønborg J; Høfsten DE; Ahtarovski KA; Bang LE; Helqvist S; Kyhl K; Køber L; Kelbæk H; Vejlstrup N; Holmvang L; Engstrøm T
    Circ Cardiovasc Interv; 2018 Sep; 11(9):e006842. PubMed ID: 30354595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction.
    Koyama T; Munakata M; Akima T; Miyamoto K; Kanki H; Ishikawa S
    J Vis Exp; 2019 May; (147):. PubMed ID: 31205316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postconditioning reduces enzymatic infarct size and improves microvascular reperfusion in patients with ST-segment elevation myocardial infarction.
    Araszkiewicz A; Grygier M; Pyda M; Rajewska J; Michalak M; Lesiak M; Grajek S
    Cardiology; 2014; 129(4):250-7. PubMed ID: 25402666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of Non-Infarct-Related Artery Disease on Infarct Size and Outcomes (from the CRISP-AMI Trial).
    Shah R; Clare RM; Chiswell K; Jones WS; Kumar AS; Thiele H; Smalling RW; Chandra P; Cohen M; Perera D; Chew DP; French JK; Blaxill J; Ohman EM; Patel MR
    Am J Med; 2016 Dec; 129(12):1307-1315. PubMed ID: 27542611
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myocardial Damage in Patients With Deferred Stenting After STEMI: A DANAMI-3-DEFER Substudy.
    Lønborg J; Engstrøm T; Ahtarovski KA; Nepper-Christensen L; Helqvist S; Vejlstrup N; Kyhl K; Schoos MM; Ghotbi A; Göransson C; Bertelsen L; Holmvang L; Pedersen F; Jørgensen E; Saunamäki K; Clemmensen P; De Backer O; Kløvgaard L; Høfsten DE; Køber L; Kelbæk H;
    J Am Coll Cardiol; 2017 Jun; 69(23):2794-2804. PubMed ID: 28595694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Meta-analysis of randomized controlled trials comparing percutaneous coronary intervention with aspiration thrombectomy Vs. Conventional percutaneous coronary intervention during ST-segment elevation myocardial infarction.
    Dominguez AC; Bittl JA; El-Hayek G; Contreras E; Tamis-Holland JE
    Catheter Cardiovasc Interv; 2016 Jun; 87(7):1203-10. PubMed ID: 26699698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of acute infarct-related artery patency before percutaneous coronary intervention on 30-day outcomes in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention in the EUROMAX trial.
    Rakowski T; Dudek D; van 't Hof A; Ten Berg J; Soulat L; Zeymer U; Lapostolle F; Anthopoulos P; Bernstein D; Deliargyris EN; Steg PG
    Eur Heart J Acute Cardiovasc Care; 2018 Sep; 7(6):514-521. PubMed ID: 28631502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. INNOVATION Study (Impact of Immediate Stent Implantation Versus Deferred Stent Implantation on Infarct Size and Microvascular Perfusion in Patients With ST-Segment-Elevation Myocardial Infarction).
    Kim JS; Lee HJ; Woong Yu C; Kim YM; Hong SJ; Park JH; Choi RK; Choi YJ; Park JS; Kim TH; Jang HJ; Joo HJ; Cho SA; Ro YM; Lim DS
    Circ Cardiovasc Interv; 2016 Dec; 9(12):. PubMed ID: 27965296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial.
    Engstrøm T; Kelbæk H; Helqvist S; Høfsten DE; Kløvgaard L; Holmvang L; Jørgensen E; Pedersen F; Saunamäki K; Clemmensen P; De Backer O; Ravkilde J; Tilsted HH; Villadsen AB; Aarøe J; Jensen SE; Raungaard B; Køber L;
    Lancet; 2015 Aug; 386(9994):665-71. PubMed ID: 26347918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.